You are here

BMMNC and Interventional Education for ASD

A recent STEM CELLS Translational Medicine article from researchers led by Liem Nguyen Thanh (Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam) describes the results of a recent clinical trial that aimed to evaluate the safety and efficacy of autologous bone marrow mononuclear cell (BMMNC) transplantation combined with educational intervention for children with autism spectrum disorder (ASD). The findings suggest that cell therapy and educational intervention may improve clinical manifestations, such as social communication, language, and daily skills, in children with ASD; however, additional studies with control groups should be performed in the future to obtain a more comprehensive and accurate conclusion.